Exhibit 99.1
Executive Vice President and
Chief Financial Officer
(615) 614-4929
HEALTHWAYS REPORTS SECOND-QUARTER EARNINGS
OF $0.26 PER DILUTED SHARE
RAISES 2009 REVENUE AND EARNINGS GUIDANCE
SIGNS FIRST WHOLEHEALTH CONTRACT WITH FORTUNE 100 COMPANY
NASHVILLE, Tenn. (July 23, 2009) – Healthways, Inc. (NASDAQ: HWAY) today announced financial results for the second quarter and six months ended June 30, 2009. Total revenues for the quarter were $177.8 million compared with revenues of $193.0 million for the three months ended June 30, 2008. Net income for the second quarter of 2009 was $8.9 million, or $0.26 per diluted share, which was one cent above the Company’s earnings guidance range. Net income for the second quarter of 2008 was $16.3 million, or $0.46 per diluted share.
COMPARISON OF COMPONENTS OF NET INCOME PER DILUTED SHARE
| | | Three Months Ended June 30, | | |
| | | 2009 | | | | 2009 | | | | 2008 | | |
| | | Actual | | | | Guidance | | | | Actual | | |
Domestic | | $ | 0.31 | | | | $ | 0.27 – 0.29 | | | | $ | 0.49 | | |
International | | | (0.05 | ) | | | | (0.05) – (0.04 | ) | | | | (0.02 | ) | |
Net income per diluted share | | $ | 0.26 | | | | $ | 0.22 – 0.25 | | | | $ | 0.46 | (1) | |
(1) Figures do not add due to rounding.
“We are pleased with our second-quarter performance,” said Ben R. Leedle, Jr., chief executive officer of Healthways. “As was true with our first quarter, our results were primarily driven by stronger than anticipated revenues from our Silver Sneakers® fitness program. In addition, we benefited from higher than expected organic growth in our current customer base and lower than expected attrition in our billed lives. We also continued to experience positive contracting momentum during the quarter, signing contracts with new and existing customers across our continuum of health promotion, prevention and chronic care management solutions.
“We are also pleased to report that, excluding $40.0 million in cash payments related to a previously announced legal settlement, we generated substantial cash flow from operations totaling $31.5 million for the second quarter for a total of $70.0 million for the first half of the year. In addition, we reduced our long-term debt by $14.1 million and invested $10.7 million for the quarter in capital expenditures, primarily related to the accelerating development of the Embrace operating platform.”
- MORE -
HWAY Reports Second-Quarter Results
Signing of Our First WholeHealth Contract
“Throughout 2009, we have discussed two strategic priorities for Healthways and our intention to complete major milestones this year in each,” continued Mr. Leedle. “The first priority is the ongoing development of an order-of-magnitude increase in our value proposition by introducing our WholeHealth solution. This solution, in addition to improving health and reducing direct healthcare costs, targets a much larger impact on employer profitability by lowering the costs of lost productivity due to health-related reasons. The second priority is the completion of our proprietary next generation technology platform known as Embrace. This platform, which is essential to our WholeHealth solution, enables us to integrate data from all the healthcare entities interacting with an individual. Embrace enables the delivery of our integrated solutions and ongoing communications between the individual and their medical and health experts, using any method desired, including venue-based face-to-face; print; phone; mobile and remote devices; on-line; emerging media; and any combination thereof. Simply put, our WholeHealth solution will help keep healthy people healthy, reduce risks for future disease by mitigating unhealthy lifestyle habits and, through evidence-based medicine, support people who already have a disease or persistent condition.
“It is with great pleasure, therefore, that we announce the signing of our first WholeHealth contract with a Fortune 100 company that is one of the country’s largest employers. Through this multi-year contract, we will provide to approximately 200,000 employees and dependents our WholeHealth solution designed to deliver measureable and sustained improvements in health and well-being, while lowering medical costs and improving health related productivity. Healthways will:
| • | Deliver the full scope of our WholeHealth solution, identifying, engaging and enabling employees and their family members to improve their health and well-being through individualized plans regardless of health status or age; |
| • | Integrate all of the employer’s health programs, and health and healthcare cost data – irrespective of supplier – through use of our proprietary Embrace platform; |
| • | Employ the Gallup-Healthways Well-Being IndexTM to baseline the population and identify areas of focus for new interventions; and |
| • | Measure progress against the goal of value creation through improved health and well-being, reduced medical expense and improved health-related productivity. |
“Through this first WholeHealth contract, we will complete major milestones in each of the strategic priorities discussed above. More important, we will be establishing a new standard for comprehensive, integrated care, which we expect will produce a significant advance toward our ultimate goal of helping individuals achieve fully optimized well-being. With the success of our WholeHealth solution, we expect to gain a significant competitive advantage in responding to employers’ needs for a healthier, higher performing and less costly workforce.”
Financial Guidance
Based on the performance of the Company’s domestic operations for the first six months of 2009, Healthways today increased its guidance for 2009 revenues to a range of $685 million to $700 million from the previous range of $652 million to $680 million. This revision includes a new range for revenues from domestic operations of $668 million to $680 million, up from $635 million to $660 million previously. Guidance for 2009 revenues from international operations remains unchanged in a range of $17 million to $20 million.
HWAY Reports Second-Quarter Results
Page 3
July 23, 2009
COMPARISON OF COMPONENTS OF REVENUES FOR THE YEAR ENDING DECEMBER 31, 2009 (GUIDANCE) AND THE YEAR ENDED DECEMBER 31, 2008
(Dollars in millions)
| | | Twelve Months | | |
| | | Ending | | | | Ended | | |
| | | Dec. 31, 2009 | | | | Dec. 31, 2008 | | |
| | | (Guidance) | | | | (Actual) | | |
Domestic | | $ | 668.0 – 680.0 | | | | $ | 731.3 | | |
International | | | 17.0 – 20.0 | | | | | 15.4 | | |
Total Company | | $ | 685.0 – 700.0 | | | | $ | 746.7 | | |
Due to the anticipated increase in revenues, Healthways has also raised its 2009 earnings guidance. The Company’s new guidance for 2009 adjusted net income per diluted share, which excludes previously announced lawsuit settlement costs, is in a range of $0.97 to $1.05 compared with the previous range of $0.90 to $1.04. This new earnings guidance reflects the margin impact from fitness programs, which account for a significant majority of the higher than anticipated revenues for 2009, as well as from increased spending in preparation for January 1, 2010 contract launches, including the market-leading contract discussed above. As a result, guidance for 2009 adjusted net income per diluted share includes a new range for domestic operations of $1.07 to $1.13 compared with $1.00 to $1.12 previously, while the contribution from international operations remains unchanged. The Company’s guidance for net income per diluted share for the third quarter of 2009 is in a range of $0.20 to $0.24, including $0.22 to $0.25 expected from domestic operations and a net cost impact of $0.02 to $0.01 from international operations.
COMPARISON OF COMPONENTS OF NET INCOME PER DILUTED SHARE
See page 8 for a reconciliation of GAAP and non-GAAP results
| | | Twelve Months | | | | Three Months | | |
| | | Ending | | | | Ended | | | | Ending | | |
| | | Dec. 31, 2009 | | | | Dec. 31, 2008 | | | | September 30, 2009 | | |
| | | (Guidance) | | | | (Actual) | | | | (Guidance) | | |
Domestic, excluding lawsuit settlement costs | | $ | 1.07 – 1.13 | | | | $ | 1.20 | | | | $ | 0.22 – 0.25 | | |
International | | | (0.10) – (0.08 | ) | | | | (0.10 | ) | | | | (0.02)– (0.01 | ) | |
Adjusted net income per diluted share | | | 0.97 – 1.05 | | | | | 1.10 | | | | | 0.20 – 0.24 | | |
Lawsuit settlement costs | | | (0.73 | ) | | | | — | | | | | — | | |
Net income per diluted share | | $ | 0.24 – 0.32 | | | | $ | 1.10 | | | | $ | 0.20 – 0.24 | | |
Summary
Mr. Leedle concluded, “Despite the economic downturn, we produced better than anticipated revenue and earnings for the second quarter and strengthened our financial position. We were pleased with the ability of many of our health plan customers to hold onto and, in some cases, expand their membership. Through the ongoing expansion of our domestic and international business and continuing investment in our industry-leading capabilities, we are positioning the Company for the long-term growth that our current contracting experience implies and health care reform around the world requires.
HWAY Reports Second-Quarter Results
Page 4
July 23, 2009
“In this regard, the signing of our first WholeHealth contract with a Fortune 100 company represents a tremendous milestone for Healthways and the healthcare industry. This contract is further tangible evidence of both the accelerating momentum in demand for integrated solutions and our leadership in bringing such powerful solutions to market. As we have experienced repeatedly in our long history as a leading industry innovator, we expect both the quality of our WholeHealth solution and our first-mover advantage to enhance our ability to continue driving improved health and well-being, as well as lower healthcare costs, for millions of people around the world.”
Conference Call
Healthways will hold a conference call to discuss this release today at 5:00 p.m. Eastern Time. Investors will have the opportunity to listen to the conference call live over the Internet by going to www.healthways.com and clicking Investor Relations, or by going to www.earnings.com, at least 15 minutes early to register, download and install any necessary audio software. For those who cannot listen to the live broadcast, a telephonic replay will be available for one week at 719-457-0820, code 1046670, and the replay will also be available on the Company’s web site for the next 12 months.
Safe Harbor Provisions
This press release contains forward-looking statements, including our guidance and financial expectations for future periods, which are based upon current expectations and involve a number of risks and uncertainties. Those forward-looking statements include all statements that are not historical statements of fact and those regarding the intent, belief or expectations of the Company, including, without limitation, all statements regarding the Company’s future earnings and results of operations. In order for the Company to utilize the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, investors are hereby cautioned that the following important factors, among others, may affect these forward-looking statements. Consequently, actual operations and results may differ materially from those expressed in these forward-looking statements. The important factors include but are not limited to: the Company’s ability to sign and implement new contracts for Health and Care Support solutions; the Company’s ability to accurately forecast performance and the timing of revenue recognition under the terms of its contracts with customers ahead of data collection and reconciliation in order to provide forward-looking guidance; the impact of any new or proposed legislation, regulations and interpretations relating to the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, including the potential expansion to Phase II for Medicare Health Support programs and any legislative or regulatory changes with respect to Medicare Advantage; the Company’s ability to reach mutual agreement with the Centers for Medicare and Medicaid Services (CMS) with respect to the Company’s results under Phase I of Medicare Health Support; the Company’s ability to anticipate the rate of market acceptance of Health and Care Support solutions in potential international markets; the ability of the Company to accurately forecast the costs necessary to implement the Company’s strategy of establishing a presence in international markets; the risks associated with foreign currency exchange rate fluctuations and the Company’s ability to hedge against such fluctuations; the Company’s ability to retain existing health plan customers if they decide to take programs in-house or are acquired by other health plans which already have or are not interested in Health and Care Support programs; the risks associated with a significant concentration of the Company’s revenues with a limited number of customers; the Company’s ability to effect cost savings and clinical outcomes improvements under
HWAY Reports Second-Quarter Results
Page 5
July 23, 2009
Health and Care Support contracts and reach mutual agreement with customers with respect to cost savings, or to effect such savings and improvements within the time frames contemplated by the Company; the ability of the Company to achieve estimated annualized revenue in backlog in the manner and within the timeframe the Company expects, which is based on certain estimates regarding the implementation of the Company’s services; the ability of the Company and/or its customers to enroll participants in the Company’s Health and Care Support programs in a manner and within the timeframe anticipated by the Company; the ability of the Company’s customers to provide timely and accurate data that is essential to the operation and measurement of the Company’s performance under the terms of its contracts; the Company’s ability to favorably resolve contract billing and interpretation issues with its customers; the Company’s ability to service its debt and make principal and interest payments as those payments become due; the risks associated with changes in macroeconomic conditions, which may reduce the demand and/or the timing of purchases for the Company’s services from customers or potential customers, reduce the number of covered lives of the Company’s existing customers, restrict the Company’s ability to obtain additional financing, or impact the availability of credit under the Company’s credit agreement; counterparty risk associated with our interest rate swap agreements; the Company’s ability to integrate acquired businesses or technologies into the Company’s business; the impact of any impairment of the Company’s goodwill or other intangible assets; the Company’s ability to develop new products and deliver outcomes on those products; the Company’s ability to renew and/or maintain contracts with its customers under existing terms or restructure these contracts on terms that would not have a material negative impact on the Company’s results of operations; the Company’s ability to obtain adequate financing to provide the capital that may be necessary to support the Company’s operations and to support or guarantee the Company’s performance under new contracts; unusual and unforeseen patterns of healthcare utilization by individuals with diabetes, cardiac, respiratory and/or other diseases or conditions for which the Company provides services; the ability of the Company’s customers to maintain the number of covered lives enrolled in the plans during the terms of the agreements; the impact of litigation involving the Company and/or its subsidiaries; the impact of future state, federal, and international health care and other applicable legislation and regulations on the Company’s ability to deliver its services and on the financial health of the Company’s customers and their willingness to purchase the Company’s services; and other risks detailed in the Company’s Annual Report on Form 10-K for the fiscal year ended August 31, 2008 and other filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise any such forward-looking statements.
About Healthways
Healthways is the leading provider of specialized, comprehensive solutions to help millions of people maintain or improve their health and well-being and, as a result, reduce overall costs. Healthways' solutions are designed to help healthy individuals stay healthy, mitigate and slow the progression of disease associated with family or lifestyle risk factors and promote the best possible health for those already affected by disease. Our proven, evidence-based programs provide highly specific and personalized interventions for each individual in a population, irrespective of age or health status, and are delivered to consumers by phone, mail, internet and face-to-face interactions, both domestically and internationally. Healthways also provides a national, fully accredited complementary and alternative Health Provider Network, offering convenient access to individuals who seek health services outside of, and in conjunction with, the traditional healthcare system. For more information, please visit www.healthways.com.
HWAY Reports Second-Quarter Results
Page 6
July 23, 2009
HEALTHWAYS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except per share data)
| | Three Months Ended | | Six Months Ended | |
| | June 30, | | June 30, | |
| | 2009 | | 2008 | | 2009 | | 2008 | |
| | | | | | | | | | | | | |
Revenues | | $ | 177,836 | | $ | 193,044 | | $ | 360,572 | | $ | 373,984 | |
Cost of services (exclusive of depreciation and amortization of $8,540, $9,371, $17,326, and $17,800, respectively, included below) | | | 127,762 | | | 128,069 | | | 260,599 | | | 256,256 | |
Selling, general & administrative expenses | | | 18,449 | | | 18,972 | | | 37,234 | | | 37,663 | |
Depreciation and amortization | | | 11,949 | | | 13,055 | | | 24,199 | | | 24,864 | |
| | | | | | | | | | | | | |
Operating income | | | 19,676 | | | 32,948 | | | 38,540 | | | 55,201 | |
Gain on sale of investment | | | — | | | — | | | (2,581 | ) | | — | |
Interest expense | | | 4,142 | | | 5,275 | | | 8,202 | | | 10,162 | |
Legal settlement and related costs | | | — | | | — | | | 39,956 | | | — | |
| | | | | | | | | | | | | |
Income (loss) before income taxes | | | 15,534 | | | 27,673 | | | (7,037 | ) | | 45,039 | |
Income tax expense (benefit) | | | 6,658 | | | 11,348 | | | (1,100 | ) | | 18,511 | |
| | | | | | | | | | | | | |
Net income (loss) | | $ | 8,876 | | $ | 16,325 | | $ | (5,937 | ) | $ | 26,528 | |
| | | | | | | | | | | | | |
Earnings (loss) per share: | | | | | | | | | | | | | |
Basic | | $ | 0.26 | | $ | 0.48 | | $ | (0.18 | ) | $ | 0.76 | |
| | | | | | | | | | | | | |
Diluted | | $ | 0.26 | | $ | 0.46 | | $ | (0.17 | ) | $ | 0.73 | |
| | | | | | | | | | | | | |
Weighted average common shares | | | | | | | | | | | | | |
and equivalents: | | | | | | | | | | | | | |
Basic | | | 33,689 | | | 33,797 | | | 33,679 | | | 34,916 | |
Diluted | | | 34,186 | | | 35,167 | | | 34,125 | | | 36,440 | |
| | | | | | | | | | | | | |
HWAY Reports Second-Quarter Results
Page 7
July 23, 2009
Healthways, Inc.
Statistical Information
(Unaudited)
| | June 30, | | June 30, | |
| | 2009 | | 2008 | |
Operating Statistics | | | | | | | |
Domestic commercial available lives | | | 195,400,000 | | | 189,400,000 | |
Domestic commercial billed lives | | | 35,800,000 | | | 30,400,000 | |
HWAY Reports Second-Quarter Results
Page 8
July 23, 2009
Healthways, Inc.
Reconciliation of Non-GAAP Measures to GAAP Measures
(Unaudited)
Reconciliation of Domestic EPS Guidance Excluding Lawsuit Settlement Costs and Reconciliation of Adjusted EPS Guidance to EPS (Loss) Guidance, GAAP Basis
| | | Twelve Months Ending | |
| | | December 31, 2009 | |
Domestic EPS guidance excluding lawsuit settlement costs (1) | | | $ | 1.07 – 1.13 | |
International EPS (loss) guidance | | | | (0.10) – (0.08 | ) |
Adjusted EPS guidance (2) | | | $ | 0.97 – 1.05 | |
EPS (loss) attributable to lawsuit settlement costs (3) | | | | (0.73 | ) |
EPS guidance, GAAP basis | | | $ | 0.24 – 0.32 | |
(1) Domestic EPS guidance excluding lawsuit settlement costs is a non-GAAP financial measure. The Company excludes EPS (loss) attributable to lawsuit settlement costs from this measure because of its comparability to the Company's historical operating results. The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management. You should not consider Domestic EPS guidance excluding lawsuit settlement costs in isolation or as a substitute for EPS guidance determined in accordance with accounting principles generally accepted in the United States.
(2) Adjusted EPS guidance is a non-GAAP financial measure. The Company excludes EPS (loss) attributable to lawsuit settlement costs from this measure because of its comparability to the Company's historical operating results. The Company believes it is useful to investors to provide disclosures of its operating results and guidance on the same basis as that used by management. You should not consider Adjusted EPS guidance in isolation or as a substitute for EPS guidance determined in accordance with accounting principles generally accepted in the United States.
(3) EPS (loss) attributable to lawsuit settlement costs consists of pre-tax charges of $40.0 million related to the Company’s settlement of a qui tam lawsuit.
Reconciliation of Operating Cash Flow excluding Lawsuit Settlement Costs to
Operating Cash Flow, GAAP basis
(in millions)
| | | Three Months Ending | |
| | | June 30, 2009 | |
Operating cash flow excluding lawsuit settlement costs (4) | | | $ | 31.5 | |
Operating cash flow attributable to lawsuit settlement costs | | | | (40.0 | ) |
Operating cash flow, GAAP basis | | | $ | (8.5 | ) |
(4) Operating cash flow excluding lawsuit settlement costs is a non-GAAP financial measure. The Company excludes operating cash flow attributable to lawsuit settlement costs from this measure and provides operating cash flow excluding lawsuit settlement costs because of its comparability to the Company's historical operating cash flow. The Company believes it is useful to investors to provide disclosures of its cash flow on the same basis as that used by management. You should not consider operating cash flow excluding lawsuit settlement costs in isolation or as a substitute for operating cash flow determined in accordance with accounting principles generally accepted in the United States.
HWAY Reports Second-Quarter Results
Page 9
July 23, 2009
HEALTHWAYS, INC.
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands)
ASSETS
| | June 30, | | | | December 31, | |
| | 2009 | | | | 2008 | |
Current assets: | | | | | | | | | |
Cash and cash equivalents | | $ | 6,517 | | | | $ | 5,157 | |
Accounts receivable, net | | | 118,477 | | | | | 115,108 | |
Prepaid expenses | | | 11,451 | | | | | 13,479 | |
Other current assets | | | 8,770 | | | | | 3,810 | |
Income taxes receivable | | | 8,676 | | | | | — | |
Deferred tax asset | | | 26,884 | | | | | 30,488 | |
Total current assets | | | 180,775 | | | | | 168,042 | |
| | | | | | | | | |
Property and equipment: | | | | | | | | | |
Leasehold improvements | | | 40,755 | | | | | 34,635 | |
Computer equipment and related software | | | 143,688 | | | | | 138,369 | |
Furniture and office equipment | | | 28,713 | | | | | 29,610 | |
Capital projects in process | | | 26,101 | | | | | 17,462 | |
| | | 239,257 | | | | | 220,076 | |
Less accumulated depreciation | | | (124,087 | ) | | | | (108,635 | ) |
| | | 115,170 | | | | | 111,441 | |
| | | | | | | | | |
Other assets | | | 8,518 | | | | | 18,089 | |
| | | | | | | | | |
Customer contracts, net | | | 30,006 | | | | | 32,715 | |
Other intangible assets, net | | | 66,940 | | | | | 68,207 | |
Goodwill, net | | | 484,584 | | | | | 484,596 | |
| | | | | | | | | |
Total assets | | $ | 885,993 | | | | $ | 883,090 | |
| | | | | | | | | |
HWAY Reports Second-Quarter Results
Page 10
July 23, 2009
HEALTHWAYS, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share data)
(Unaudited)
LIABILITIES AND STOCKHOLDERS’ EQUITY
| | June 30, | | | | December 31, | |
| | 2009 | | | | 2008 | |
Current liabilities: | | | | | | | |
Accounts payable | $ | 16,106 | | | $ | 21,633 | |
Accrued salaries and benefits | | 47,860 | | | | 33,161 | |
Accrued liabilities | | 31,202 | | | | 26,294 | |
Deferred revenue | | 7,050 | | | | 6,904 | |
Contract billings in excess of earned revenue | | 78,393 | | | | 71,406 | |
Income taxes payable | | — | | | | 8,034 | |
Current portion of long-term debt | | 3,239 | | | | 2,035 | |
Current portion of long-term liabilities | | 4,279 | | | | 4,609 | |
Total current liabilities | | 188,129 | | | | 174,076 | |
| | | | | | | |
Long-term debt | | 297,360 | | | | 304,372 | |
Long-term deferred tax liability | | 7,628 | | | | 8,073 | |
Other long-term liabilities | | 36,877 | | | | 39,533 | |
| | | | | | | |
Stockholders’ equity: | | | | | | | |
Preferred stock | | | | | | | |
$.001 par value, 5,000,000 shares | | | | | | | |
authorized, none outstanding | | — | | | | — | |
Common stock | | | | | | | |
$.001 par value, 120,000,000 shares authorized, | | | | | | | |
33,704,407 and 33,648,976 shares outstanding | | 34 | | | | 34 | |
Additional paid-in capital | | 217,965 | | | | 213,461 | |
Retained earnings | | 142,569 | | | | 148,506 | |
Accumulated other comprehensive loss | | (4,569 | ) | | | (4,965 | ) |
Total stockholders’ equity | | 355,999 | | | | 357,036 | |
| | | | | | | |
Total liabilities and stockholders’ equity | $ | 885,993 | | | $ | 883,090 | |
| | | | | | | |
HWAY Reports Second-Quarter Results
Page 11
July 23, 2009
HEALTHWAYS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)
| | Six Months Ended June 30, | |
| | 2009 | | | | 2008 | |
Cash flows from operating activities: | | | | | | | | | |
Net income (loss) | | $ | (5,937 | ) | | | $ | 26,528 | |
Adjustments to reconcile net income (loss) to net cash provided by | | | | | | | | | |
operating activities, net of business acquisitions: | | | | | | | | | |
Depreciation and amortization | | | 24,199 | | | | | 24,864 | |
Amortization of deferred loan costs | | | 738 | | | | | 583 | |
Gain on sale of investment | | | (2,581 | ) | | | | — | |
Loss on disposal of property and equipment | | | 726 | | | | | — | |
Share-based employee compensation expense | | | 5,306 | | | | | 8,385 | |
Excess tax benefits from share-based payment arrangements | | | (56 | ) | | | | (3,305 | ) |
Increase in accounts receivable, net | | | (3,365 | ) | | | | (29,174 | ) |
(Increase) decrease in other current assets | | | (5,825 | ) | | | | 943 | |
Increase in accounts payable | | | 482 | | | | | 899 | |
Increase in accrued salaries and benefits | | | 14,675 | | | | | 6,964 | |
Increase (decrease) in other current liabilities | | | (360 | ) | | | | 20,664 | |
Deferred income taxes | | | 2,305 | | | | | (8,025 | ) |
Other | | | 3,187 | | | | | 10,131 | |
Increase in other assets | | | (1,018 | ) | | | | (1,598 | ) |
Payments on other long-term liabilities | | | (2,461 | ) | | | | (1,934 | ) |
Net cash flows provided by operating activities | | | 30,015 | | | | | 55,925 | |
| | | | | | | | | |
Cash flows from investing activities: | | | | | | | | | |
Acquisition of property and equipment | | | (22,241 | ) | | | | (49,418 | ) |
Sale of investment | | | 11,626 | | | | | — | |
Change in restricted cash | | | (538 | ) | | | | — | |
Other | | | (2,286 | ) | | | | (3,198 | ) |
Net cash flows used in investing activities | | | (13,439 | ) | | | | (52,616 | ) |
| | | | | | | | | |
Cash flows from financing activities: | | | | | | | | | |
Proceeds from issuance of long-term debt | | | 165,200 | | | | | 87,287 | |
Payments of long-term debt | | | (173,035 | ) | | | | (11,342 | ) |
Deferred loan costs | | | (784 | ) | | | | — | |
Exercise of stock options | | | 139 | | | | | 3,337 | |
Excess tax benefits from share-based payment arrangements | | | 56 | | | | | 3,305 | |
Repurchases of common stock | | | — | | | | | (94,208 | ) |
Repurchase of stock options | | | (736 | ) | | | | — | |
Change in outstanding checks and other | | | (6,149 | ) | | | | — | |
Net cash flows used in financing activities | | | (15,309 | ) | | | | (11,621 | ) |
| | | | | | | | | |
HWAY Reports Second-Quarter Results
Page 12
July 23, 2009
Effect of exchange rate changes on cash | | | 93 | | | | | 287 | |
| | | | | | | | | |
Net increase (decrease) in cash and cash equivalents | | | 1,360 | | | | | (8,025 | ) |
| | | | | | | | | |
Cash and cash equivalents, beginning of period | | | 5,157 | | | | | 40,515 | |
| | | | | | | | | |
Cash and cash equivalents, end of period | | $ | 6,517 | | | | $ | 32,490 | |
